{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:41:54Z","timestamp":1788327714961,"version":"build-2803163510"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,9,24]],"date-time":"2010-09-24T00:00:00Z","timestamp":1285286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1007\/s00417-010-1520-9","type":"journal-article","created":{"date-parts":[[2010,9,23]],"date-time":"2010-09-23T09:00:12Z","timestamp":1285232412000},"page":"633-637","source":"Crossref","is-referenced-by-count":66,"title":["Delay between medical indication to anti-VEGF treatment in age-related macular degeneration can result in a loss of visual acuity"],"prefix":"10.1007","volume":"249","author":[{"given":"Philipp Sebastian","family":"Muether","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel M.","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Fauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,24]]},"reference":[{"key":"1520_CR1","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","volume":"355","author":"DM Brown","year":"2006","unstructured":"Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355:1432\u20131444. doi: 10.1056\/NEJMoa062655","journal-title":"N Engl J Med"},{"key":"1520_CR2","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.ophtha.2007.08.033","volume":"115","author":"MM Brown","year":"2008","unstructured":"Brown MM, Brown GC, Brown HC, Peet J (2008) A value-based medicine analysis of ranibizumab for the treatment of subfoveal neovascular macular degeneration. Ophthalmology 115:1039\u20131045","journal-title":"Ophthalmology"},{"key":"1520_CR3","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419\u20131431. doi: 10.1056\/NEJMoa054481","journal-title":"N Engl J Med"},{"key":"1520_CR4","unstructured":"EMEA (2007) Lucentis Combined Product Information. In: EMEA (ed) emea-combined-h715enpdf"},{"key":"1520_CR5","unstructured":"EMEA (2007) EMEA Scientific discussion LUCENTIS. In: EMEA (ed) H-715-en6, pp 54"},{"key":"1520_CR6","unstructured":"EMEA (2008) European Public Assessment Report (EPAR) LUCENTIS. In: EMEA (ed) EMEA\/H\/C\/715, pp 54"},{"key":"1520_CR7","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/sj.eye.6703053","volume":"23","author":"L Arias","year":"2009","unstructured":"Arias L, Armada F, Donate J, Garcia-Arumi J, Giralt J, Pazos B, Pinero A, Martinez F, Mondejar JJ, Ortega I, Zlateva G, Buggage R (2009) Delay in treating age-related macular degeneration in Spain is associated with progressive vision loss. Eye (Lond) 23:326\u2013333. doi: 10.1038\/sj.eye.6703053","journal-title":"Eye (Lond)"},{"key":"1520_CR8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0008-4182(05)80074-2","volume":"40","author":"A Oliver-Fernandez","year":"2005","unstructured":"Oliver-Fernandez A, Bakal J, Segal S, Shah GK, Dugar A, Sharma S (2005) Progression of visual loss and time between initial assessment and treatment of wet age-related macular degeneration. Can J Ophthalmol 40:313\u2013319. doi: 10.1139\/i05-003","journal-title":"Can J Ophthalmol"},{"key":"1520_CR9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ophtha.2007.03.008","volume":"115","author":"TY Wong","year":"2008","unstructured":"Wong TY, Chakravarthy U, Klein R, Mitchell P, Zlateva G, Buggage R, Fahrbach K, Probst C, Sledge I (2008) The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology 115:116\u2013126. doi: 10.1016\/j.ophtha.2007.03.008","journal-title":"Ophthalmology"},{"key":"1520_CR10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ajo.2007.10.004","volume":"145","author":"CD Regillo","year":"2008","unstructured":"Regillo CD, Brown DM, Abraham P, Yue H, Ianchulev T, Schneider S, Shams N (2008) Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1. Am J Ophthalmol 145:239\u2013248. doi: 10.1016\/j.ajo.2007.10.004","journal-title":"Am J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-010-1520-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-010-1520-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-010-1520-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:48:04Z","timestamp":1559058484000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-010-1520-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,24]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["1520"],"URL":"https:\/\/doi.org\/10.1007\/s00417-010-1520-9","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,24]]}}}